Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
about
Aspergillosis of bones and joints - a review from 2002 until today.Combination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data.Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.Canadian clinical practice guidelines for invasive candidiasis in adults.Guidelines for the management of bacterial and fungal infections during chemotherapy for pediatric acute leukemia or solid tumors: what is available in 2010?Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.Relevance of timing for determination of posaconazole plasma concentrationsAn observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazoleCaspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry.Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature.Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis.Supportive therapy in medical therapy of head and neck tumors.Synthesis of a highly water-soluble derivative of amphotericin B with attenuated proinflammatory activity.Disseminated Fusarium infection in a patient with acute lymphoblastic leukemia: A case report and review of the literature.Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy.Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients.Updated guidelines for managing fungal diseases in hematology patients.Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and Oncology.How I manage haematology patients with septic shock.Invasive aspergillosis in children with hematological malignancies.Invasive aspergillosis in hematopoietic stem cell and solid organ transplantation.Amphotericin B use in children: conventional and lipid-based formulations.Current issues in the clinical management of invasive aspergillosis--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009.Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy.Current issues in the clinical management of invasive candida infections--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009.Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy.Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.A practical critique of antifungal treatment guidelines for haemato-oncologists.Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective reviewOur 2015 approach to invasive pulmonary aspergillosis.Molecular fractionation and characterization of a Candida albicans fraction that increases tumor cell adhesion to hepatic endothelium.Anti-Aspergillus immunoglobulin-G testing in serum of hematopoietic stem cell transplant recipients.Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden.Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.Invasive fungal infection of the central nervous system in a patient with acute myeloid leukaemia.Invasive Candida infections in patients with haematological malignancies and hematopoietic stem cell transplant recipients: current epidemiology and therapeutic options.Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study.
P2860
Q30727401-C81B70E7-FA82-443A-8489-BD3200B9DFAEQ30873926-0E3A1E5E-29DA-4DFB-AB3D-4B07647EF974Q33723583-2F0BFDA3-6107-47F2-BE22-A4B47D6EA4B4Q34166590-78FF0309-4F24-416A-8FFA-DC6B0FB38072Q34237335-CE7BB48E-7340-429D-A0D1-023D9086D96CQ35010346-96AA85B7-28A8-4E8B-A37C-F1E6507F5A4DQ35033597-6399DD42-8FDC-49A8-AE3A-1C2C96AD60BFQ35065721-221D8981-6AE1-405F-A4E8-A8EA40189456Q35942379-CA2F0DA7-3F18-414D-B77A-3F8675752CEBQ35958060-E6EBE535-5628-46AB-AAE8-A86FC078666DQ35959480-B84909ED-9610-469B-B4E9-CF72AFCD44F1Q35959489-2C5C6E44-B501-48AC-BCB8-1A2461637B9DQ36216209-00435DE5-5BA7-4A5E-AC06-2083F56E4344Q36529853-3E06717F-E820-4B3F-B0D7-1C47B4E2797CQ37005474-95522FC7-DD8F-4180-BD05-383E78F8BF78Q37437204-064A204C-77FE-4FC9-99EF-B5403E749E58Q37682908-8A00FA8C-B4DC-4E6F-A093-A84E4BC2A8F2Q37759256-EA6D205D-C1C6-4468-94D2-9D7585647B28Q37785548-0412D731-FD23-424D-93EE-13C365EBE39AQ37805910-BDCA9AC9-0B33-4C42-A6C0-9BE71351A444Q37826436-3BCBA969-3A14-42F8-A3D3-3EA8B4C4F9D5Q37854719-82AB4AF6-23EA-411E-8EF3-5A075367945DQ37854721-DF0AA958-796C-4248-B7A7-CBB55B897F70Q37854727-76EB47B4-721C-4EDF-8DD2-D87D0DCF640BQ37868705-695152C5-C1A0-42F4-9B2E-DFB70F6FA35FQ37873552-7970CD0B-59E5-417E-A6B3-CEBFD2CC2BCAQ37873554-3EB2306C-3423-40F5-BFCC-CEF48185D41DQ37889382-3E1FE0CF-70CB-45FA-B21B-E01CDACE2467Q37956597-C54C9B74-0C32-444C-BE6F-B3CADBF32E84Q37983106-9FBD718C-4F33-4023-B6FA-941255C50544Q38111391-E6833550-DD88-4B62-8D29-3A2D980D1A75Q38391049-90077B95-B330-4DF0-B3B5-4A8317B0E865Q39486548-B68B42DE-1BF4-4506-AC68-0A44B6008C56Q39902358-BB14710B-72DB-4CD8-8F03-66F88CA06412Q40263137-49E51C2E-D672-48DB-9587-7797A567461BQ40333474-C2BAB8B1-4A6E-40C5-BF2C-40123A60B34EQ41516719-E36B2F7D-1BAF-426C-A841-806FA068B139Q42114420-42F2132A-CDB2-4CE8-B200-36DF0F4C1F89Q42119440-2D76B0A8-9880-4555-B67B-3BE53D09067EQ43718029-77317521-EEAE-4DBF-867E-156A9616374C
P2860
Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of invasive fungal i ...... ematology and Oncology (DGHO).
@en
Treatment of invasive fungal i ...... ectious Diseases Working Party
@nl
type
label
Treatment of invasive fungal i ...... ematology and Oncology (DGHO).
@en
Treatment of invasive fungal i ...... ectious Diseases Working Party
@nl
prefLabel
Treatment of invasive fungal i ...... ematology and Oncology (DGHO).
@en
Treatment of invasive fungal i ...... ectious Diseases Working Party
@nl
P2093
P50
P1433
P1476
Treatment of invasive fungal i ...... Hematology and Oncology (DGHO)
@en
P2093
Andrew J Ullmann
Angelika Böhme
Christian Junghanss
Dietmar Reichert
Georg Maschmeyer
Gerda Silling
Herrmann Einsele
Holger Hebart
Infectious Diseases Working Pa ...... Hematology and Oncology (DGHO)
Markus Ruhnke
P2860
P304
P356
10.1007/S00277-008-0622-5
P577
2008-10-14T00:00:00Z